Targeting KIT on innate immune cells enhances the antitumor activity of checkpoint inhibitors in vivo

od Gedrich, Richard, Seibel, Scott, LaVallee, Theresa, Eder, Joseph Paul
Wydane w J Immunother Cancer (2015)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC

od Alvarado, Diego, Ligon, Gwenda F., Lillquist, Jay S., Seibel, Scott B., Wallweber, Gerald, Neumeister, Veronique M., Rimm, David L., McMahon, Gerald, LaVallee, Theresa M.
Wydane w PLoS One (2017)